My eyebrows are raised because the sp tanked AH instead of shooting to the moon. May just be non serious investors taking profits. Hope it goes back to $5 again.
Ricardo, are you familiar with study design? I'm a bit worried the GPNMB expression cutoff of 25%. If <25% of tumors have GPNMB, did they lump that into the 5%? IF they lumped all those with expression >15 or 20% could they have had a higher number of patients that actually responded? Just wondering if the 25% was set after data analysis and not prior.